Erythrodermic psoriasis treated with ustekinumab: an Italian multicenter retrospective analysis.

导出 LinkOut

翻译打印收藏纠错

作者： Leonardo,Pescitelli ^[1] ; Valentina,Dini ^[2] ; Paolo,Gisondi ^[3] ; Francesco,Loconsole ^[4] ; Stefano,Piaserico ^[5] ; Angelo,Piccirillo ^[6] ; Giuseppe,Stinco ^[7] ; Enzo,Errichetti ^[7] ; Marina,Talamonti ^[8] ; Lara,Tripo ^[1] ; Walter,Volpi ^[1] ; Francesca,Prignano ^[9]

作者单位： Division of Clinical, Preventive, and Oncologic Dermatology, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy. ^[1] Department of Dermatology, University of Pisa, Pisa, Italy. ^[2] Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy. ^[3] Dermatology and Venereology Unit, Department of Biomedical Sciences and Human Oncology, University of Bari, Bari, Italy. ^[4] Dermatology Unit, Department of Medicine, University of Padova, Padova, Italy. ^[5] Department of Dermatology, San Carlo Hospital, Potenza, Italy. ^[6] Institute of Dermatology, Department of Experimental and Clinical Medicine, University of Udine, Udine, Italy. ^[7] Department of Dermatology, University of Rome Tor Vergata, Rome, Italy. ^[8] Division of Clinical, Preventive, and Oncologic Dermatology, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy. Electronic address: francesca.prignano@unifi.it. ^[9]

关键词 Biologics Efficacy Erythrodermic psoriasis Psoriasis Safety Ustekinumab